Heart Test Laboratories, Inc. (HSCS) Price & Analysis

Compare

187 Followers

HSCS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$2.36 - $6.47

Previous CloseN/A

Volume8.49K

Average Volume (3M)171.48K

Market Cap

$8.37M

Enterprise Value$3.57M

Total Cash (Recent Filing)$1.10M

Total Debt (Recent Filing)$2.99M

Price to Earnings (P/E)―

Beta1.52

Next Earnings

Sep 11, 2025

EPS Estimate

-1.72

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.54

Shares Outstanding2,244,247

10 Day Avg. Volume143,186

30 Day Avg. Volume171,476

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)16.05

Price to Sales (P/S)757.08

P/FCF Ratio-0.44

Enterprise Value/Market Cap0.43

Enterprise Value/Revenue821.52

Enterprise Value/Gross Profit1.45K

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price Target

$7.50

Price Target Upside121.24% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Regulatory ApprovalThe company expects to submit its MyoVista device for FDA approval, which could lead to significant advancements in their product offerings.

Reimbursement OpportunitiesCMS reimbursement for AI-ECG technology paves the way for monetization, creating potential revenue opportunities for HeartSciences.

Strategic PartnershipsHeartSciences signed its first MyoVista Insights Platform customer, Westcliffe Health Innovations, in the UK.

Bears Say

Financial PerformanceThe company's earnings per share came in lower than the consensus estimate, indicating higher expenses than anticipated.

Funding NeedsThe company will need to raise substantial cash to maintain its operations until it reaches its expected monetization phase.

Regulatory DelaysFDA submission for the MyoVista Insights software platform is now expected to be delayed to CY1H26, pushing out initial revenue projections to late CY26.

Heart Test Laboratories, Inc. News

Heart Test Laboratories Enters Equity Distribution Agreement

An announcement from Heart Test Laboratories, Inc. ( ($HSCS) ) is now available. Heart Test Laboratories, Inc. has...

9d ago

HSCS

Heart Test Laboratories Raises $4.3 Million in Offering

An update from Heart Test Laboratories, Inc. ( ($HSCS) ) is now available. HeartSciences, Inc. announced that as...

14d ago

HSCS

Heart Test Laboratories Raises $2.8 Million in Offering

Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an update. Heart Test Laboratories, Inc. announced that it...

23d ago

HSCS

Heart Test Laboratories Raises $1.7M in Regulation A Offering

Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an update. Heart Test Laboratories, Inc. announced on July...

1M ago

HSCS

Heart Test Laboratories Updates Bylaws to Align with Texas Law

Heart Test Laboratories, Inc. ( ($HSCS) ) has issued an announcement. On June 27, 2025, HeartSciences Inc. amended...

1M ago

HSCS

Heart Test Laboratories Receives FDA Breakthrough Designation

Heart Test Laboratories, Inc. ( ($HSCS) ) just unveiled an announcement. On June 4, 2025, HeartSciences Inc. announced...

2M ago

HSCS

HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm

HeartSciences (HSCS) announced that the U.S. Food and Drug Administration has granted Breakthrough Device designationless than BDD, for...

2M ago

HSCS

Heart Test Laboratories Files Certificate for Preferred Stock

Heart Test Laboratories, Inc. ( ($HSCS) ) has issued an update. HeartSciences Inc. recently filed an Offering Statement...

2M ago

HSCS

Heart Test Laboratories Secures Foundational Patent for AI-ECG

Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an update. On June 3, 2025, HeartSciences Inc. announced...

2M ago

HSCS

HeartSciences announces grant by USPTO for ECG assessment of heart function

HeartSciences (HSCS) announced the grant by the United States Patent and Trademark Office, USPTO, of a foundational patent...

2M ago

HSCS

HeartSciences signs first MyoVista Insights platform customer

HeartSciences (HSCS) announced the signing of its first commercial customer for the MyoVista Insights platform: Westcliffe Health Innovations,...

3M ago

HSCS

Heart Test Laboratories Announces $15M Securities Offering

Heart Test Laboratories, Inc. ( ($HSCS) ) just unveiled an update. HeartSciences Inc. announced a securities offering with...

3M ago

HSCS

Heart Test Labs Granted Nasdaq Compliance Extension

Heart Test Laboratories, Inc. ( ($HSCS) ) just unveiled an announcement. HeartSciences Inc. has been granted an extension...

3M ago

HSCS

HeartSciences appoints Nadkarni, Lampart, Vai to Scientific Advisory Board

HeartSciences (HSCS) announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua Lampert, MD, and Dr. Akhil Vaid,...

3M ago

HSCS

HSCS FAQ

What was Heart Test Laboratories, Inc.’s price range in the past 12 months?

Heart Test Laboratories, Inc. lowest stock price was $2.36 and its highest was $6.47 in the past 12 months.

What is Heart Test Laboratories, Inc.’s market cap?

Heart Test Laboratories, Inc.’s market cap is $8.37M.

When is Heart Test Laboratories, Inc.’s upcoming earnings report date?

Heart Test Laboratories, Inc.’s upcoming earnings report date is Sep 11, 2025 which is in 29 days.

How were Heart Test Laboratories, Inc.’s earnings last quarter?

Heart Test Laboratories, Inc. released its earnings results on Mar 13, 2025. The company reported -$2.545 earnings per share for the quarter, missing the consensus estimate of -$2.305 by -$0.24.

Is Heart Test Laboratories, Inc. overvalued?

According to Wall Street analysts Heart Test Laboratories, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Heart Test Laboratories, Inc. pay dividends?

Heart Test Laboratories, Inc. does not currently pay dividends.

What is Heart Test Laboratories, Inc.’s EPS estimate?

Heart Test Laboratories, Inc.’s EPS estimate is -1.72.

How many shares outstanding does Heart Test Laboratories, Inc. have?

Heart Test Laboratories, Inc. has 2,244,247 shares outstanding.

What happened to Heart Test Laboratories, Inc.’s price movement after its last earnings report?

Heart Test Laboratories, Inc. reported an EPS of -$2.545 in its last earnings report, missing expectations of -$2.305. Following the earnings report the stock price went up 2.703%.

Which hedge fund is a major shareholder of Heart Test Laboratories, Inc.?

Currently, no hedge funds are holding shares in HSCS

Company Description

Heart Test Laboratories, Inc.

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Heart Test Laboratories, Inc. (HSCS) Earnings & Revenues

Historic Earnings Reports

HSCS Stock 12 Month Forecast

Average Price Target

$7.50

▲(121.24% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","4":"$4","7":"$7","10":"$10","13":"$13"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,4,7,10,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.05,3.7384615384615385,4.426923076923076,5.115384615384615,5.803846153846154,6.492307692307692,7.18076923076923,7.869230769230769,8.557692307692307,9.246153846153845,9.934615384615384,10.623076923076923,11.311538461538461,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.05,3.3923076923076922,3.7346153846153847,4.076923076923077,4.419230769230769,4.7615384615384615,5.1038461538461535,5.446153846153846,5.788461538461538,6.13076923076923,6.473076923076923,6.815384615384615,7.157692307692307,{"y":7.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.05,3.046153846153846,3.042307692307692,3.0384615384615383,3.0346153846153845,3.0307692307692307,3.026923076923077,3.023076923076923,3.019230769230769,3.0153846153846153,3.0115384615384615,3.0076923076923077,3.003846153846154,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.06,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.89,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.4,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.9,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.28,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.82,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.23,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.56,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.75,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.48,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.69,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.9,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.05,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >